A Phase 2 Trial of Hypofractionated-Intensity Modulated Radiation Therapy (Hypo-IMRT) Combined With Temozolomide (TMZ) and Bevacizumab (BEV) for Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) Meeting Abstract (Web of Science)

cited authors

  • Carlson, J. A.; Ney, D.; Reddy, K.; Gaspar, L. E.; Kavanagh, B. D.; Damek, D.; Lillehei, K. O.; Chen, C.

publication date

  • September 1, 2014

webpage

published in

start page

  • S284

end page

  • S285

volume

  • 90